Current update on cellular and molecular mechanisms of hereditary angioedema

作者: Hannah H. Walford , Bruce L. Zuraw

DOI: 10.1016/J.ANAI.2013.12.023

关键词:

摘要: Abstract Objective To provide an update on the molecular mechanisms of hereditary angioedema (HAE). Data Sources MEDLINE and PubMed databases were searched to identify pertinent articles using following key terms: , C1 inhibitor bradykinin contact system factor XII mechanism pathophysiology severity permeability estrogen . Study Selections Articles selected based their relevance subject matter. Results Although biochemical basis "classic" HAE is known result from esterase (C1INH) deficiency, a new form, with normal C1INH, has been identified. types I II are caused by mutations in SERPING1 gene that decreased plasma levels functional C1INH. In F12 have identified subset individuals, but genetic defect remains unknown most patients. The primary mediator swelling bradykinin, product increases vascular permeability. disease highly variable may be influenced polymorphisms other genes factors, such as hormones, trauma, stress, infection. Conclusion Hereditary heterogeneous disorder complex pathophysiology. Implicated include FXII patients C1INH deficiency levels, respectively. Disease variable.

参考文章(56)
Bruce L. Zuraw, Hereditary Angioedema New England Journal of Medicine. ,vol. 359, pp. 1027- 1036 ,(2008) , 10.1056/NEJMCP0803977
Virginia H. Donaldson, Richard R. Evans, A biochemical abnormality in hereditary angioneurotic edema: Absence of serum inhibitor of C′1-esterase The American Journal of Medicine. ,vol. 35, pp. 37- 44 ,(1963) , 10.1016/0002-9343(63)90162-1
José Giménez, M. Paz García, Mar Serna, Bárbara Bonacasa, Luis F. Carbonell, Tomás Quesada, Isabel Hernández, 17β-Oestradiol enhances the acute hypotensive effect of captopril in female ovariectomized spontaneously hypertensive rats Experimental Physiology. ,vol. 91, pp. 715- 722 ,(2006) , 10.1113/EXPPHYSIOL.2006.033449
Allen P. Kaplan, Kusumam Joseph, The bradykinin-forming cascade and its role in hereditary angioedema. Annals of Allergy Asthma & Immunology. ,vol. 104, pp. 193- 204 ,(2010) , 10.1016/J.ANAI.2010.01.007
Fleur Bossi, Fabio Fischetti, Domenico Regoli, Paolo Durigutto, Barbara Frossi, Fernand Gobeil, Berhane Ghebrehiwet, Ellinor I. Peerschke, Marco Cicardi, Francesco Tedesco, Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency Journal of Allergy and Clinical Immunology. ,vol. 124, pp. 1303- 1310.e4 ,(2009) , 10.1016/J.JACI.2009.08.007
Karen E. Binkley, Alvin Davis, Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. The Journal of Allergy and Clinical Immunology. ,vol. 106, pp. 546- 550 ,(2000) , 10.1067/MAI.2000.108106
Kusumam Joseph, Baby G. Tholanikunnel, Anette Bygum, Berhane Ghebrehiwet, Allen P. Kaplan, Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II The Journal of Allergy and Clinical Immunology. ,vol. 132, pp. 470- 475 ,(2013) , 10.1016/J.JACI.2013.03.026
MICHAEL M FRANK, JEFFREY A GELFAND, JOHN P ATKINSON, Hereditary Angioedema: the Clinical Syndrome and Its Management Annals of Internal Medicine. ,vol. 84, pp. 580- 593 ,(1976) , 10.7326/0003-4819-84-5-580
E Verpy, E Couture-Tosi, E Eldering, M Lopez-Trascasa, P Späth, T Meo, M Tosi, Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. Journal of Clinical Investigation. ,vol. 95, pp. 350- 359 ,(1995) , 10.1172/JCI117663
M Quastel, R Harrison, M Cicardi, C A Alper, F S Rosen, Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. Journal of Clinical Investigation. ,vol. 71, pp. 1041- 1046 ,(1983) , 10.1172/JCI110831